Pankreas neuro-endokriene gewasse (NET) groei gewoonlik stadig, en die laboratorium monitor die gewas vir tekens van groei deur middel van beeldingstoetse. Pasiënte met NET wat uit die pankreas versprei, het gewoonlik simptome soos diarree of hormonale probleme. Dit kan gebruik word vir middels soos octreotide, lanreotide, diazoxide, en protonpompremmers, wat die groei van die tumor kan inhibeer.
When the patient’s symptoms cannot be controlled or the scan shows signs of tumor growth, further treatment is required, and chemotherapy or targeted drugs (such as sunitinib or everolimus) can be used. For people with poorly differentiated tumors (neuroendocrine carcinoma), chemotherapy is the first choice. For patients who have spread to the liver, choose surgery or ablation technology for treatment according to their own conditions. For adults with somatostatin (a hormone) receptor-positive pancreatic neuroendocrine tumor, the radiopharmaceutical Lutathera (l Lu177 dotatate) is a treatment option.
As alle haalbare behandelings nie meer werk nie, oorweeg dit dan om aan kliniese proewe deel te neem om nuwe terapieë te toets. Deelname aan kliniese proewe sal waarskynlik sommige pasiënte bevoordeel.
